313 related articles for article (PubMed ID: 30291840)
1. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
[TBL] [Abstract][Full Text] [Related]
2. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015.
Yu O; Schulze-Rath R; Grafton J; Hansen K; Scholes D; Reed SD
Am J Obstet Gynecol; 2020 Jul; 223(1):94.e1-94.e10. PubMed ID: 31954156
[TBL] [Abstract][Full Text] [Related]
3. Incidence, prevalence, and trends in endometriosis diagnosis: a United States population-based study from 2006 to 2015.
Christ JP; Yu O; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2021 Nov; 225(5):500.e1-500.e9. PubMed ID: 34147493
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive myomectomy: practice trends and differences between Black and non-Black women within a large integrated healthcare system.
Zaritsky E; Le A; Tucker LY; Ojo A; Weintraub MR; Raine-Bennett T
Am J Obstet Gynecol; 2022 Jun; 226(6):826.e1-826.e11. PubMed ID: 35101407
[TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
Wise LA; Palmer JR; Stewart EA; Rosenberg L
Obstet Gynecol; 2005 Mar; 105(3):563-8. PubMed ID: 15738025
[TBL] [Abstract][Full Text] [Related]
6. Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019.
Yu O; Christ JP; Schulze-Rath R; Covey J; Kelley A; Grafton J; Cronkite D; Holden E; Hilpert J; Sacher F; Micks E; Reed SD
Am J Obstet Gynecol; 2023 Jul; 229(1):39.e1-39.e12. PubMed ID: 37061077
[TBL] [Abstract][Full Text] [Related]
7. Growth of uterine leiomyomata among premenopausal black and white women.
Peddada SD; Laughlin SK; Miner K; Guyon JP; Haneke K; Vahdat HL; Semelka RC; Kowalik A; Armao D; Davis B; Baird DD
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19887-92. PubMed ID: 19047643
[TBL] [Abstract][Full Text] [Related]
8. Associations between Race/Ethnicity, Uterine Fibroids, and Minimally Invasive Hysterectomy in the VA Healthcare System.
Callegari LS; Katon JG; Gray KE; Doll K; Pauk S; Lynch KE; Uchendu US; Zephyrin L; Gardella C
Womens Health Issues; 2019; 29(1):48-55. PubMed ID: 30293778
[TBL] [Abstract][Full Text] [Related]
9. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
10. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
11. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in Uterine Fibroid Treatment Among Veterans Using VA Health Care.
Katon JG; Bossick A; Carey C; Christy A; Doll K; Gatsby E; Gray KE; Lynch KE; Moy E; Owens S; Washington DL; Callegari LS
Womens Health Issues; 2023; 33(4):405-413. PubMed ID: 37105835
[TBL] [Abstract][Full Text] [Related]
13. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.
Borahay MA; Fang X; Baillargeon JG; Kilic GS; Boehning DF; Kuo YF
Am J Obstet Gynecol; 2016 Dec; 215(6):750.e1-750.e8. PubMed ID: 27371355
[TBL] [Abstract][Full Text] [Related]
14. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998-2002.
Becker ER; Spalding J; DuChane J; Horowitz IR
J Natl Med Assoc; 2005 Oct; 97(10):1336-42. PubMed ID: 16353655
[TBL] [Abstract][Full Text] [Related]
15. Uterine fibroids, active component females, U.S. Armed Forces, 2001-2010.
Armed Forces Health Surveillance Center (AFHSC)
MSMR; 2011 Dec; 18(12):10-3. PubMed ID: 22229335
[TBL] [Abstract][Full Text] [Related]
16. Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022.
Nieh C; Mabila SL
MSMR; 2024 Feb; 31(2):9-15. PubMed ID: 38466970
[TBL] [Abstract][Full Text] [Related]
17. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
Baird DD; Dunson DB; Hill MC; Cousins D; Schectman JM
Am J Obstet Gynecol; 2003 Jan; 188(1):100-7. PubMed ID: 12548202
[TBL] [Abstract][Full Text] [Related]
18. Herpes Simplex Virus Type 2 Seroprevalence and Incidence and Growth of Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women.
Moore KR; Harmon QE; Baird DD
Am J Epidemiol; 2021 Oct; 190(10):2158-2162. PubMed ID: 34038935
[TBL] [Abstract][Full Text] [Related]
19. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
20. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.
Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M
J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
